Tim Forshew

Company: Inivata

Job title: Head of Science & Innovation and Co- Founder

Seminars:

13.00 | 11.00 – Practical Applications of ctDNA Testing for Residual Disease & Recurrence 1:00 pm

• RaDaR assay has industry leading sensitivity – why is this important? • Using residual disease and recurrence opens new options for clinical trial design • Data from a recent NSCLC clinical trialRead more

day: Day Two